Metavia INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
MTVA
Metavia INCMetaVia Inc. filed an S-1MEF to register an additional $6.9 million in Class A and Class B Units, including common stock and warrants, for a public offering.
NASDAQ
MTVA
Metavia INCMetaVia Inc. announced a public offering of Class A and Class B Units to raise approximately $6.0 million for working capital and clinical development of its cardiometabolic drug candidates, despite ongoing net losses and a 'going concern' warning.
NASDAQ
MTVA
Metavia INCMetaVia Inc. announced a public offering of up to 1.57 million units to fund its clinical programs, following positive top-line data from its Phase 1 trial for obesity and Phase 2a trial for MASH.
NASDAQ
MTVA
Metavia INCS-1: NeuroBo Pharmaceuticals Files for Resale of Up to 17.2 Million Shares Following Private Placement
NeuroBo Pharmaceuticals has filed a registration statement for the resale of up to 17,175,579 shares of its common stock by selling securityholders, following a recent private placement.